DOXORUBICIN INDUCED CARDIOTOXICITY

Clinical trials for DOXORUBICIN INDUCED CARDIOTOXICITY explained in plain language.

Never miss a new study

Get alerted when new DOXORUBICIN INDUCED CARDIOTOXICITY trials appear

Sign up with your email to follow new studies for DOXORUBICIN INDUCED CARDIOTOXICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Asthma drug may shield hearts from chemo damage

Disease control Completed

This study tested whether montelukast, a common asthma medication, could help protect the heart from damage caused by the chemotherapy drug doxorubicin in breast cancer patients. Fifty patients were split into two groups: one received montelukast and the other received a placebo …

Matched conditions: DOXORUBICIN INDUCED CARDIOTOXICITY

Phase: NA • Sponsor: Damanhour University • Aim: Disease control

Last updated Mar 23, 2026 15:18 UTC

DOXORUBICIN INDUCED CARDIOTOXICITY

Get alerted when new DOXORUBICIN INDUCED CARDIOTOXICITY trials appear

Asthma drug may shield hearts from chemo damage